353
Views
36
CrossRef citations to date
0
Altmetric
Review Articles

Combination of targeted daunorubicin liposomes and targeted emodin liposomes for treatment of invasive breast cancer

, , , , , , , , & show all
Pages 245-258 | Received 05 Jun 2019, Accepted 13 Aug 2019, Published online: 02 Sep 2019

References

  • De La Mare JA, Contu L, Hunter MC, et al. Breast cancer: current developments in molecular approaches to diagnosis and treatment. Recent Pat Anticancer Drug Discov. 2014;9:153–175.
  • Liu JY, Wu XY, Wu GN, et al. FOXQ1 promotes cancer metastasis by PI3K/AKT signaling regulation in colorectal carcinoma. Am J Transl Res. 2017;9:2207–2218.
  • Chida T, Miura Y, Cabral H, et al. Epirubicin-loaded polymeric micelles effectively treat axillary lymph nodes metastasis of breast cancer through selective accumulation and pH-triggered drug release. J Control Release. 2018;292:130–140.
  • Parchment RE, Doroshow JH. Theory and practice of clinical pharmacodynamics in oncology drug development. Semin Oncol. 2016;43:427–435.
  • Stamatakos M, Stefanaki C, Xiromeritis K, et al. Breast cancer in reproductive age. The new plaque or just myth? Surg Oncol. 2011;20:e169–e174.
  • Partridge AH, Carey LA. Unmet needs in clinical research in breast cancer: where do we need to go? Clin Cancer Res. 2017;23:2611–2616.
  • Angara K, Borin TF, Arbab AS. Vascular mimicry: a novel neovascularization mechanism driving anti-angiogenic therapy (AAT) resistance in glioblastoma. Transl Oncol. 2017;10:650–660.
  • Naito Y, Yoshioka Y, Yamamoto Y, et al. How cancer cells dictate their microenvironment: present roles of extracellular vesicles. Cell Mol Life Sci. 2017;74:697–713.
  • Shen J, Wang B, Zhang T, et al. Suppression of non-small cell lung cancer growth and metastasis by a novel small molecular activator of RECK. Cell Physiol Biochem. 2018;45:1807–1817.
  • Yuan R, Li S, Geng H, et al. Reversing the polarization of tumor-associated macrophages inhibits tumor metastasis. Int Immunopharmacol. 2017;49:30–37.
  • Deshpande P, Jhaveri A, Pattni B, et al. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer. Drug Deliv. 2018;25:517–532.
  • Au Yeung CL, Co NN, Tsuruga T, et al. Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1. Nat Commun. 2016;7:11150.
  • Ruan S, He Q, Gao H. Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma. Nanoscale. 2015;7:9487–9496.
  • Gao H, Zhang Q, Yu Z, et al. Cell-penetrating peptide-based intelligent liposomal systems for enhanced drug delivery. Curr Pharm Biotechnol. 2014;15:210–219.
  • Dong X, Fu J, Yin X, et al. Emodin: a review of its pharmacology, toxicity and pharmacokinetics. Phytother Res. 2016;30:1207–1218.
  • Li Z, Lin Y, Zhang S, et al. Emodin regulates neutrophil phenotypes to prevent hypercoagulation and lung carcinogenesis. J Transl Med. 2019;17:90.
  • Hou X, Wei W, Fan Y, et al. Study on synthesis and bioactivity of biotinylated emodin. Appl Microbiol Biotechnol. 2017;101:5259–5266.
  • Capranico G, Butelli E, Zunino F. Change of the sequence specificity of daunorubicin-stimulated topoisomerase II DNA cleavage by epimerization of the amino group of the sugar moiety. Cancer Res. 1995;55:312–317.
  • Angelova A, Garamus VM, Angelov B, et al. Advances in structural design of lipid-based nanoparticle carriers for delivery of macromolecular drugs, phytochemicals and anti-tumor agents. Adv Colloid Interface Sci. 2017;249:331–345.
  • Zerkoune L, Lesieur S, Putaux JL, et al. Mesoporous self-assembled nanoparticles of biotransesterified cyclodextrins and nonlamellar lipids as carriers of water-insoluble substances. Soft Matter. 2016;12:7539–7550.
  • Carita AC, Eloy JO, Chorilli M, et al. Recent advances and perspectives in liposomes for cutaneous drug delivery. Curr Med Chem. 2018;25:606–635.
  • Nguyen TX, Huang L, Gauthier M, et al. Recent advances in liposome surface modification for oral drug delivery. Nanomedicine. 2016;11:1169–1185.
  • Moya ML, Lopez-Lopez M. Preparation and characterization of new liposomes. Bactericidal activity of cefepime encapsulated into cationic liposomes. Pharmaceutics. 2019;11:69.
  • Song XL, Ju RJ, Xiao Y, et al. Application of multifunctional targeting epirubicin liposomes in the treatment of non-small-cell lung cancer. Int J Nanomedicine. 2017;12:7433–7451.
  • Wang X, Cheng L, Xie HJ, et al. Functional paclitaxel plus honokiol micelles destroying tumour metastasis in treatment of non-small-cell lung cancer. Artif Cells Nanomed Biotechnol. 2018;46:1154–1169.
  • Bosserman L, Rogers K, Willis C, et al. Application of a drug-induced apoptosis assay to identify treatment strategies in recurrent or metastatic breast cancer. PLoS One. 2015;10:e0122609.
  • Christensen ME, Jansen ES, Sanchez W, et al. Flow cytometry based assays for the measurement of apoptosis-associated mitochondrial membrane depolarisation and cytochrome c release. Methods. 2013;61:138–145.
  • Guiu S, Wolfer A, Jacot W, et al. Invasive lobular breast cancer and its variants: how special are they for systemic therapy decisions? Crit Rev Oncol Hematol. 2014;92:235–257.
  • Goins B, Phillips WT, Bao A. Strategies for improving the intratumoral distribution of liposomal drugs in cancer therapy. Expert Opin Drug Deliv. 2016;13:873–889.
  • Kang JH, Jang WY, Ko YT. The effect of surface charges on the cellular uptake of liposomes investigated by live cell imaging. Pharm Res. 2017;34:704–717.
  • Quiros-Gonzalez I, Tomaszewski MR, Aitken SJ, et al. Optoacoustics delineates murine breast cancer models displaying angiogenesis and vascular mimicry. Br J Cancer. 2018;118:1098–1106.
  • Ju RJ, Cheng L, Qiu X, et al. Hyaluronic acid modified daunorubicin plus honokiol cationic liposomes for the treatment of breast cancer along with the elimination vasculogenic mimicry channels. J Drug Target. 2018;26:793–805.
  • Abdouh M, Hamam D, Gao ZH, et al. Exosomes isolated from cancer patients' sera transfer malignant traits and confer the same phenotype of primary tumors to oncosuppressor-mutated cells. J Exp Clin Cancer Res. 2017;36:113.
  • Song Y, Sheng Z, Xu Y, et al. Magnetic liposomal emodin composite with enhanced killing efficiency against breast cancer. Biomater Sci. 2019;7:867–875.
  • Senoo A, Nagatoishi S, Moberg A, et al. Inhibition of homophilic dimerization and disruption of cell adhesion by P-cadherin-specific small molecules from SPR-based assays. Chem Commun. 2018;54:5350–5353.
  • You Y, Huan P, Wang X, et al. The potential roles of a laminin receptor in adhesion and apoptosis of cells of the marine bivalve Meretrix meretrix. PLoS One. 2012;7:e47104.
  • Guo JR, Yin L, Chen YQ, et al. Autologous blood transfusion augments impaired wound healing in diabetic mice by enhancing lncRNA H19 expression via the HIF-1α signaling pathway. Cell Commun Signal. 2018;16:84.
  • Azimi I. The interplay between HIF-1 and calcium signalling in cancer. Int J Biochem Cell Biol. 2018;97:73–77.
  • Shen KH, Hung JH, Chang CW, et al. Solasodine inhibits invasion of human lung cancer cell through downregulation of miR-21 and MMPs expression. Chem-Biol Interact. 2017;268:129–135.
  • Trillsch F, Kuerti S, Eulenburg C, et al. E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer. Br J Cancer. 2016;114:213–220.
  • Kobayashi N, Ikesue A, Majumdar S, et al. Inhibition of e-cadherin-mediated homotypic adhesion of Caco-2 cells: a novel evaluation assay for peptide activities in modulating cell-cell adhesion. J Pharmacol Exp Ther. 2006;317:309–316.
  • Baek SH, Ko JH, Lee JH, et al. Ginkgolic acid inhibits invasion and migration and TGF-beta-induced EMT of lung cancer cells through PI3K/Akt/mTOR inactivation. J Cell Physiol. 2017;232:346–354.
  • Zhao MH, Yuan L, Meng LY, et al. Quercetin-loaded mixed micelles exhibit enhanced cytotoxic efficacy in non-small cell lung cancer in vitro. Exp Ther Med. 2017;14:5503–5508.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.